Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double‐blind, randomized, placebo‐controlled clinical trial

AIMS: Previous uncontrolled studies suggested a possible benefit of intravenous immunoglobulin (IVIg) in parvovirus B19 (B19V)‐related dilated cardiomyopathy (DCM). This randomized, double‐blind, placebo‐controlled, single‐centre trial investigated the benefits of IVIg beyond conventional therapy in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hazebroek, Mark R., Henkens, Michiel T.H.M., Raafs, Anne G., Verdonschot, Job A.J., Merken, Jort J., Dennert, Robert M., Eurlings, Casper, Abdul Hamid, Myrurgia A., Wolffs, Petra F.G., Winkens, Bjorn, Brunner‐La Rocca, Hans‐Peter, Knackstedt, Christian, van Paassen, Pieter, van Empel, Vanessa P.M., Heymans, Stephane R.B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2021
Materias:
Focus on Myocarditis, Cardiomyopathy and Amyloidosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048650/
https://www.ncbi.nlm.nih.gov/pubmed/33347677
http://dx.doi.org/10.1002/ejhf.2082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048650/
https://www.ncbi.nlm.nih.gov/pubmed/33347677
http://dx.doi.org/10.1002/ejhf.2082

Ejemplares similares